Informações de Indivior PLC

Mais detalhes de Indivior PLC Empresa

Indivior PLC is a pharmaceutical company. The Company is engaged in developing medicines to treat substance use disorders (SUD), serious mental illnesses, and opioid overdose. It has a pipeline of product candidates designed to address other chronic conditions and co-occurring disorders of SUD, including alcohol use disorder and cannabis use disorder, and co-morbidities, including schizophrenia. Its core products include SUBLOCADE (buprenorphine extended release) monthly injection; SUBOXONE Film (buprenorphine and naloxone sublingual film); SUBOXONE Tablet (buprenorphine and naloxone sublingual tablets), and SUBUTEX Tablet (buprenorphine sublingual tablets). Its products for the treatment of opioid disorders (OUD) are OPVEE (nalmefene) nasal spray for opioid overdose reversal, and PERSERIS (risperidone) extended-release injectable suspension for the treatment of schizophrenia in adults in the United States. Its portfolio of products is available in 37 countries.



Código da empresaINDV

Nome da EmpresaIndivior PLC

Data de listagemDec 24, 2014

CEOMr. Joseph J. (Joe) Ciaffoni

Número de funcionários1030

Tipo de títulosOrdinary Share

Fim do ano fiscalDec 24

Endereço234 Bath Road

CidadeSLOUGH

Bolsa de valoresNASDAQ Global Select Consolidated

PaísUnited Kingdom

Código postalSL1 4EE

Telefone448043791090

Sitehttps://www.indivior.com/en

Código da empresaINDV

Data de listagemDec 24, 2014

CEOMr. Joseph J. (Joe) Ciaffoni

Executivos da empresa Indivior PLC



Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.25%

Mr. Christian Heidbreder

Chief Scientific Officer

132.64K

+42.74%

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

121.74K

--

Mr. Hillel West

Chief Manufacturing and Supply Officer

121.72K

+338.91%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

56.00K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

15.00K

--

Ms. Juliet Thompson

Senior Non-Executive Independent Director

9.63K

+150.00%

Dr. Keith Humphreys

Non-Executive Independent Director

3.88K

+63.05%

Mr. Jeffrey W. (Jeff) Burris, Esq., J.D.

Chief Legal Officer

760.00

--

Mr. Stuart (Tony) Kingsley

Independent Non-Executive Director

--

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Vishal Kalia

Chief Impact and Strategy Officer

137.46K

+3.25%

Mr. Christian Heidbreder

Chief Scientific Officer

132.64K

+42.74%

Ms. Cynthia (Cindy) Cetani

Chief Integrity and Compliance Officer

121.74K

--

Mr. Hillel West

Chief Manufacturing and Supply Officer

121.72K

+338.91%

Mr. Joseph J. (Joe) Ciaffoni

Chief Executive Officer, Director

56.00K

--

Mr. Daniel A. (Dan) Ninivaggi, J.D.

Non-Executive Independent Director

15.00K

--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out

FY2025Q2

FY2025Q1

FY2024

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Sem dados

Por RegiãoUSD

Nome

Receita

Proporção

United States

256.00M

84.77%

Rest of World

46.00M

15.23%

Por Empresa

Por Região

Sem dados

Distribuição de ações

Atualizado em: sex, 15 de ago

Investidores

Tipos de investidores

Investidores

Proporção

Oaktree Capital Management, L.P.

8.82%

Deerfield Management Company, L.P.

8.46%

Two Seas Capital LP

7.41%

Goldman Sachs International

7.19%

BlackRock Investment Management (UK) Ltd.

6.62%

Outro

61.50%

Investidores

Proporção

Oaktree Capital Management, L.P.

8.82%

Deerfield Management Company, L.P.

8.46%

Two Seas Capital LP

7.41%

Goldman Sachs International

7.19%

BlackRock Investment Management (UK) Ltd.

6.62%

Outro

61.50%

Tipos de investidores

Investidores

Proporção

Hedge Fund

40.46%

Investment Advisor/Hedge Fund

24.19%

Investment Advisor

15.17%

Research Firm

13.06%

Individual Investor

3.87%

Pension Fund

0.44%

Bank and Trust

0.31%

Family Office

0.31%

Insurance Company

0.04%

Outro

2.14%

Participação acionária institucional



Atualizado em: qua, 1 de out

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q3

372

118.02M

94.53%

+2.51M

2025Q2

354

123.13M

98.21%

+4.02M

2025Q1

380

119.99M

96.15%

-1.70M

2024Q4

382

116.83M

93.64%

-10.43M

2024Q3

369

117.73M

91.72%

-15.91M

2024Q2

352

119.29M

90.10%

-8.99M

2024Q1

341

129.79M

96.57%

+3.79M

2023Q4

322

124.43M

92.28%

+2.93M

2023Q3

321

114.40M

84.40%

+17.06M

2023Q2

296

115.50M

83.90%

+12.51M

Ver Mais

Atividade dos acionistas



Nome

Ações detidas

Proporção

Variação

Var. %

Data

Oaktree Capital Management, L.P.

11.01M

8.82%

--

Jun 30, 2025

Deerfield Management Company, L.P.

10.57M

8.47%

--

Jun 30, 2025

Two Seas Capital LP

10.33M

8.28%

-1.33M

-11.43%

Sep 03, 2025

Goldman Sachs International

8.97M

7.19%

+759.17K

+9.24%

Jun 30, 2025

BlackRock Investment Management (UK) Ltd.

8.27M

6.63%

+8.24M

+28135.71%

Jun 27, 2025

Madison Avenue Partners LP

7.92M

6.35%

+130.09K

+1.67%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

5.04M

4.04%

+5.03M

+68055.48%

Jun 30, 2025

Rubric Capital Management LP

4.65M

3.72%

-55.00K

-1.17%

Jun 30, 2025

Point72 Asset Management, L.P.

3.57M

2.86%

+1.69M

+89.42%

Jun 30, 2025

The Vanguard Group, Inc.

5.63M

4.51%

+1.02M

+22.15%

Jun 30, 2025

Ver Mais

ETFs Relacionados



Atualizado em: qui, 6 de nov

Nome

Proporção

Lattice Hartford Multifactor Small Cap ETF

0.84%

Federated Hermes MDT Small Cap Core ETF

0.36%

Janus Henderson Small Cap Growth Alpha ETF

0.35%

ProShares Ultra Nasdaq Biotechnology

0.31%

Invesco Nasdaq Biotechnology ETF

0.3%

Franklin US Small Cap Multifactor Index ETF

0.27%

Vanguard US Multifactor ETF

0.24%

Pacer US Small Cap Cash Cows ETF

0.22%

First Trust Active Factor Small Cap ETF

0.22%

Principal U.S. Small-Cap ETF

0.16%

Ver Mais

Lattice Hartford Multifactor Small Cap ETF

Proporção0.84%

Federated Hermes MDT Small Cap Core ETF

Proporção0.36%

Janus Henderson Small Cap Growth Alpha ETF

Proporção0.35%

ProShares Ultra Nasdaq Biotechnology

Proporção0.31%

Invesco Nasdaq Biotechnology ETF

Proporção0.3%

Franklin US Small Cap Multifactor Index ETF

Proporção0.27%

Vanguard US Multifactor ETF

Proporção0.24%

Pacer US Small Cap Cash Cows ETF

Proporção0.22%

First Trust Active Factor Small Cap ETF

Proporção0.22%

Principal U.S. Small-Cap ETF

Proporção0.16%

Dividendo



Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Sem dados

Desdobramento de ações



Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados